Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Damian Crowther PhD FRCP

Damian Crowther PhD FRCP

individual
Fund operatorEcosystem influencer

About

Damian Crowther is a British clinician-scientist and biotech operator with a background in clinical neurology, University of Cambridge neuroscience research, and early-stage drug discovery. Parkinson's UK describes him as a Venture Partner at SV's Dementia Discovery Fund and Entrepreneur in Residence at Cambridge Innovation Capital, after serving as Director and Head of Early R&D at AstraZeneca Neuroscience. He is also publicly associated with founding or helping commercialize ventures including GPnotebook and TRIMTECH Therapeutics.

Areas of interest

neuroscienceneurodegenerationParkinson's diseasedementiadrug discoverybiotech commercializationtargeted protein degradationdigital health